Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab

Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause and often confounded with psoriasis. It is characterised by hyperkeratotic follicular papules, scaly erythematous plaques, palmoplantar keratoderma, and a progression to generalised erythroderma. Here, we report the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanfstingl, Kathrin, Pekar-Lukacs, Agnes, Motz, Reinhard, Guenova, Emmanuella, Hoetzenecker, Wolfram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981592/
https://www.ncbi.nlm.nih.gov/pubmed/29867429
http://dx.doi.org/10.1159/000488902
_version_ 1783328075838128128
author Hanfstingl, Kathrin
Pekar-Lukacs, Agnes
Motz, Reinhard
Guenova, Emmanuella
Hoetzenecker, Wolfram
author_facet Hanfstingl, Kathrin
Pekar-Lukacs, Agnes
Motz, Reinhard
Guenova, Emmanuella
Hoetzenecker, Wolfram
author_sort Hanfstingl, Kathrin
collection PubMed
description Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause and often confounded with psoriasis. It is characterised by hyperkeratotic follicular papules, scaly erythematous plaques, palmoplantar keratoderma, and a progression to generalised erythroderma. Here, we report the case of a 68-year-old man with pityriasis rubra pilaris, who was successfully treated with ixekizumab, an interleukin-17A inhibitor.
format Online
Article
Text
id pubmed-5981592
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-59815922018-06-04 Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab Hanfstingl, Kathrin Pekar-Lukacs, Agnes Motz, Reinhard Guenova, Emmanuella Hoetzenecker, Wolfram Case Rep Dermatol Single Case Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause and often confounded with psoriasis. It is characterised by hyperkeratotic follicular papules, scaly erythematous plaques, palmoplantar keratoderma, and a progression to generalised erythroderma. Here, we report the case of a 68-year-old man with pityriasis rubra pilaris, who was successfully treated with ixekizumab, an interleukin-17A inhibitor. S. Karger AG 2018-05-02 /pmc/articles/PMC5981592/ /pubmed/29867429 http://dx.doi.org/10.1159/000488902 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Hanfstingl, Kathrin
Pekar-Lukacs, Agnes
Motz, Reinhard
Guenova, Emmanuella
Hoetzenecker, Wolfram
Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
title Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
title_full Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
title_fullStr Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
title_full_unstemmed Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
title_short Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
title_sort successful treatment of pityriasis rubra pilaris with ixekizumab
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981592/
https://www.ncbi.nlm.nih.gov/pubmed/29867429
http://dx.doi.org/10.1159/000488902
work_keys_str_mv AT hanfstinglkathrin successfultreatmentofpityriasisrubrapilariswithixekizumab
AT pekarlukacsagnes successfultreatmentofpityriasisrubrapilariswithixekizumab
AT motzreinhard successfultreatmentofpityriasisrubrapilariswithixekizumab
AT guenovaemmanuella successfultreatmentofpityriasisrubrapilariswithixekizumab
AT hoetzeneckerwolfram successfultreatmentofpityriasisrubrapilariswithixekizumab

Ejemplares similares